HOPE Therapeutics™, Inc. (“HOPE”), an interventional psychiatry network owned by NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), announces the acquisition of a strategic interest in Cohen and Associates, LLC (“Cohen, LLC”) and its incorporation into the HOPE Network. Additionally, Rebecca Cohen, MD has joined HOPE as Medical Director, overseeing medical standards of care throughout HOPE’s Florida locations. Cohen, LLC is one of the premier interventional Psychiatry clinics in the region. The clinic offers a full range of treatments for suicidal depression, PTSD and other CNS disorders, including ketamine, Transcranial Magnetic Stimulation (“TMS”), and medication management.
Read the full article: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network //
Source: https://www.globenewswire.com/news-release/2025/10/20/3169337/0/en/HOPE-Therapeutics-Inc-and-NRx-Pharmaceuticals-Inc-NASDAQ-NRXP-Announce-Inclusion-of-Cohen-Associates-LLC-of-Sarasota-FL-into-the-HOPE-Network-and-Appointment-of-Dr-Rebecca-Cohen-as.html